Argenx to Buy Forte Biosciences for About $2.2 Billion in Cash
2026-07-27 05:32:23
Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its immunology medicines portfolio, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
交易员挪用5000万港元押注ETFNext article：
股票市场 | 中际旭创港股定价低于最高推介价
